Novozymes A/S (OTCMKTS:NVZMY) Reaches New 12-Month High at $64.15

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as $64.15 and last traded at $63.94, with a volume of 4038 shares trading hands. The stock had previously closed at $63.74.

Novozymes A/S Trading Up 1.3 %

The company has a debt-to-equity ratio of 0.30, a quick ratio of 0.80 and a current ratio of 1.30. The firm has a market capitalization of $30.40 billion, a price-to-earnings ratio of 41.09, a P/E/G ratio of 3.55 and a beta of 0.89. The business has a fifty day moving average price of $61.99 and a 200 day moving average price of $59.03.

About Novozymes A/S

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Featured Articles

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.